Cetera Advisor Networks’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.51M | Sell |
22,209
-135
| -0.6% | -$9.2K | 0.01% | 1170 |
|
|
2023
Q4 | $1.4M | Buy |
22,344
+12,971
| +138% | +$812K | 0.01% | 1162 |
|
|
2023
Q3 | $425K | Buy |
9,373
+2,274
| +32% | +$103K | ﹤0.01% | 1889 |
|
|
2023
Q2 | $399K | Sell |
7,099
-35
| -0.5% | -$1.97K | ﹤0.01% | 1886 |
|
|
2023
Q1 | $323K | Sell |
7,134
-404
| -5% | -$18.3K | ﹤0.01% | 2008 |
|
|
2022
Q4 | $306K | Buy |
7,538
+306
| +4% | +$12.4K | ﹤0.01% | 1977 |
|
|
2022
Q3 | $473K | Sell |
7,232
-700
| -9% | -$45.8K | 0.01% | 1319 |
|
|
2022
Q2 | $482K | Sell |
7,932
-550
| -6% | -$33.4K | 0.01% | 1298 |
|
|
2022
Q1 | $532K | Buy |
8,482
+2,367
| +39% | +$148K | 0.01% | 1257 |
|
|
2021
Q4 | $463K | Sell |
6,115
-4,618
| -43% | -$350K | 0.01% | 1325 |
|
|
2021
Q3 | $1.2M | Buy |
10,733
+6,789
| +172% | +$760K | 0.02% | 761 |
|
|
2021
Q2 | $638K | Buy |
3,944
+938
| +31% | +$152K | 0.01% | 1048 |
|
|
2021
Q1 | $366K | Sell |
3,006
-2,311
| -43% | -$281K | 0.01% | 1025 |
|
|
2020
Q4 | $814K | Sell |
5,317
-1,166
| -18% | -$179K | 0.02% | 606 |
|
|
2020
Q3 | $542K | Sell |
6,483
-20
| -0.3% | -$1.67K | 0.01% | 684 |
|
|
2020
Q2 | $478K | Buy |
6,503
+1,751
| +37% | +$129K | 0.01% | 712 |
|
|
2020
Q1 | $202K | Sell |
4,752
-821
| -15% | -$34.9K | 0.01% | 984 |
|
|
2019
Q4 | $341K | Buy |
+5,573
| New | +$341K | 0.01% | 895 |
|
|
2019
Q3 | – | Sell |
-4,743
| Closed | -$222K | – | 1204 |
|
|
2019
Q2 | $222K | Buy |
+4,743
| New | +$222K | 0.01% | 1040 |
|
|
2018
Q4 | – | Sell |
-11,873
| Closed | -$523K | – | 1046 |
|
|
2018
Q3 | $523K | Buy |
11,873
+2,793
| +31% | +$123K | 0.02% | 615 |
|
|
2018
Q2 | $536K | Buy |
+9,080
| New | +$536K | 0.03% | 455 |
|